Avalyn Pharma grants Erin Lavelle 26,978 options
Avalyn Pharma director Erin Lavelle received a grant of stock options covering 26,978 shares of common stock at an exercise price of $18.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Avalyn Pharma director Erin Lavelle received a grant of stock options covering 26,978 shares of common stock at an exercise price of $18.00 per share. Twenty-five percent vest on September 12, 2025, with the remaining 75% vesting in 36 equal monthly installments, subject to continued service.
Insider Trade Summary
Grant/Award: 26,978 shares
Grant/Award
1 txn
Insider
Lavelle Erin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 26,978 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 26,978 contracts (Direct)
Footnotes (1)
- F1. 25% of the shares underlying this option vest and become exercisable on September 12, 2025, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Key Figures
Option grant size: 26,978 shares
Exercise price: $18.00 per share
Post-grant derivative holdings: 26,978 options
+3 more
6 metrics
Option grant size
26,978 shares
Stock Option (Right to Buy) grant to Erin Lavelle
Exercise price
$18.00 per share
Exercise price for granted stock options
Post-grant derivative holdings
26,978 options
Total derivative securities following transaction
Initial vesting tranche
25% of 26,978 shares
Vest and become exercisable on September 12, 2025
Remaining vesting schedule
75% over 36 months
Equal monthly installments after initial vest date
Option expiration date
April 28, 2036
Expiration date of stock option grant
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date
4 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 18.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"25% of the shares underlying this option vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-04-28T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Erin Lavelle report for AVLN?
Erin Lavelle reported receiving a grant of stock options for 26,978 shares of Avalyn Pharma common stock. These options are part of compensation, not an open-market share purchase or sale, and give the right to buy shares at a fixed exercise price.
What is the exercise price of Erin Lavelle’s Avalyn Pharma stock options?
The stock options granted to Erin Lavelle have an exercise price of $18.00 per share. This price is the fixed amount she must pay per share to convert the options into common stock once the options have vested and become exercisable.
How do Erin Lavelle’s AVLN stock options vest over time?
The options vest in stages: 25% of the shares vest on September 12, 2025, while the remaining 75% vest in thirty-six equal monthly installments. Vesting is conditioned on Lavelle’s continued service on each applicable vesting date.
When do Erin Lavelle’s Avalyn Pharma stock options expire?
The reported stock options have an expiration date of April 28, 2036. After this date, any unexercised portion of the option can no longer be used to purchase common shares, even if it had previously vested and become exercisable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
